
Zydus muscular dystrophy drug receives FDA final approval
Ahmedabad: Indian drug maker Zydus Lifesciences has received final approval from the United States Food and Drug Administration (US FDA) to manufacture Jaythari(Deflazacort) tablets, indicated for the treatment of Duchenne muscular dystrophy. The approved …